Johnson & Johnson (J&J) will provide the list price of its prescription drugs in television advertisements starting in late March. The company will be the first manufacturer to take such a step, according to The New York Times.

Though healthcare organizations have started to realize AI’s potential, a health coalition led by providers, payers and vendors has made 11 policy recommendations for the technology's role in the space.

Women are less successful at receiving funds for research if the application reviewer is asked to evaluate the principal investigator, rather than the quality of the science, according to research published in The Lancet.

As the rising drug price issue has taken hold of the healthcare debate in the U.S., Democrats in Congress have introduced a bill that would allow Medicare to negotiate drug prices. 

The price for a drug that treats Lambert-Eaton Myasthenic Syndrome (LEMS), a rare neuromuscular disorder that impacts strength and impairs walking, went from cost-free to the price of a house—$375,000 to be exact. 

Here are some of the top stories from around the web covering healthcare fraud and ethics issues.

Anthem, the second largest health insurer in the nation, is facing a class action lawsuit for allegedly misleading thousands of Georgia consumers during the 2018 open enrollment period.

Approximately two-thirds of U.S.-based hospitals and acute-care facility leaders believe diagnosis-related group (DRG) optimization is still a problem that needs to be solved in revenue cycle management, according to a recent survey conducted by BESLER and HIMSS Media.